BauerA. W., KirbyW. M., SherrisJ. C., TurkN.: Antibiotic susceptibility testing by a standardized single disk method. Amer. J. Clin. Pathol., 45; 439–496 (1966).
2.
DrachG. W.: Problems in diagnosis of bacterial prostatitis: Gram-negative, Gram-positive and mixed infection. J. Urol., 111; 630 (1974).
3.
EriccsonH. N., SherrisJ. C.: Antibiotic sensitivity testing: Report of an international collaborative study. Acta Pathol. Microbiol. Scand. Sec. B, 217; 9–90 (1971).
4.
GialdroniGrassi G., FerraraA., SalaP.: Mechanism of the synergistic activity of different combination of trimethoprim, ampicillin, fosfomycin and rifampicin. Drugs Exptl. Clin. Res., 6; 269–276 (1980).
5.
MagedZ., KahfagaH.: Bacteriological and serological study of chronic prostatitis. Brit. Ven. Dis., 51; 202 (1965).
6.
NicolettiP., NovelliA., LandiniG., RuggeriM., MazzeiT., MiniE., De CarloG., CavalloA. M., RizzoM., ZuccatiG., GiannottiB., PecileP., AlecciA.: Osservazioni laboratoristiche e cliniche sul sinergismo tra fosfomicina e beta-lattamine. Chemioter. Antimicr., 3; 341–353 (1978).
PeritiP.: Rationale of fixed dose combinations of fosfomycin with beta-lactamin antibiotics: co-fosfolactamines. Drugs Exptl. Clin. Res., 6; 305–309 (1980).
9.
RavizzolaG., SmillovichG. P., CarusoA., MancaN., SavoldiE.: Studio delle combinazioni di differenti penicilline e cefalosporine con un analogo dell'acido clavulanico. Boll. Microbiol. Ind. Laboratorio, 1; 55–65 (1983).
10.
Trimethoprim sulfamethoxazole: an assessment of more than 12 years of use.Rev. Infec. Dis., 6; 196–236 (1982).
